ArticleSurgical endoscopy2026
Robotic transvaginal hybrid natural orifice transluminal endoscopic surgery (NOTES) nephrectomy: clinical experience with 23 cases.
Article in Surgical endoscopy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
backgroundThe introduction of robotic surgical platforms holds the potential to accelerate the evolution of natural orifice transluminal endoscopic surgery (NOTES). This study aimed to evaluate the feasibility and safety of robotic transvaginal hybrid NOTES nephrectomy based on a retrospective case series from our hospital.
methodsFrom August 2019 to August 2024, a total of 23 patients underwent robotic transvaginal hybrid NOTES nephrectomy at our institution. All procedures were performed using the Da Vinci Xi robotic system. Two 8-mm robotic ports were placed at the margins of the umbilicus. Another 8-mm robotic scope port was placed transvaginally via the posterior fornix. An assistant 12-mm port was placed at the suprapubic midline. After dissection of the kidney, it was removed transvaginally. All data referring to patients were recorded and analyzed. The cosmetic result was evaluated according to the Patient Scar Assessment Questionnaire and Scoring System (PSAQ). Sexual function was investigated by administering the Female Sexual Function Index (FSFI).
resultsAll 23 robotic transvaginal hybrid NOTES nephrectomy procedures were successfully completed without conversion to open surgery. The mean operative time was 188 min (range 120-330 min). The mean estimated blood loss was 216 ml (range 30-800 ml). The mean Visual Analog Scale (VAS) score at 24 h postoperatively was 2.4 (range 2-4), indicating minimal pain. The excellent cosmetic results were confirmed by the PSAQ score. Nineteen patients completed the FSFI questionnaire, and analysis did not show significant differences before and after surgery. One patient achieved spontaneous pregnancy 3 years after surgery and delivered successfully via the vaginal route.
conclusionsRobotic transvaginal hybrid NOTES nephrectomy is feasible, safe, and effective in properly selected patients, providing minimal postoperative pain and excellent cosmetic results.
Indexed as
Identifiers
42247134What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.